Zobrazeno 1 - 10
of 18
pro vyhledávání: '"L. V. Movchan"'
Publikováno v:
Медицинская иммунология, Vol 25, Iss 2, Pp 309-318 (2023)
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Externí odkaz:
https://doaj.org/article/047d1c323a7748abb86a0067192d14e1
Autor:
A. G. Kadushkin, A. D. Taganovich, L. V. Movchan, E. I. Talabaeva, A. V. Plastinina, T. V. Shman
Publikováno v:
Туберкулез и болезни лёгких, Vol 99, Iss 10, Pp 14-22 (2021)
The objective: to evaluate the ability of the combination of theophylline and budesonide to suppress proinflammatory cytokine production byblood cells in patients with chronic obstructive pulmonary disease (COPD).Subjects and Methods. Peripheral blo
Externí odkaz:
https://doaj.org/article/30879f2b72d14e59ae3bf41a7e9ac5fe
Autor:
I. A. Novikova, T. Yu. Verzhbitskaya, L. V. Movchan, G. A. Tsaur, М. V. Belevtsev, A. M. Popov
Publikováno v:
Онкогематология, Vol 13, Iss 1, Pp 73-82 (2018)
Background. Flow cytometry is one of the key technologies for acute lymphoblastic leukemia (ALL) diagnostics. Nevertheless lack of technological standards hampers implementation of immunophenotyping data in treatment protocols.Objective: development
Externí odkaz:
https://doaj.org/article/d7836d8a4dc24a98af5d2ea567f1ef29
Autor:
A. M. Popov, M. V. Belevtsev, E. V. Boyakova, T. Yu. Verzhbitskaya, L. V. Movchan, M. S. Fadeeva, А. B. Pashchenko, V. P. Savitskiy, А. A. Levadnyy, G. А. Tsaur, S. A. Kashpor, S. A. Plyasunova, L. G. Fechina, O. V. Aleynikova, A. I. Karachunskiy
Publikováno v:
Онкогематология, Vol 11, Iss 4, Pp 64-73 (2017)
We developed and implemented in multicenter setting the standardized approach for flow cytometric minimal residual disease (MRD) monitoring in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Participation of multicenter group refer
Externí odkaz:
https://doaj.org/article/3c5cd98211d04789a620de530334df1a
Autor:
L. V. Movchan
Publikováno v:
Онкогематология, Vol 7, Iss 1, Pp 22-28 (2014)
To allow minimal residual disease (MRD) monitoring using flow cytometry it is needed the optimal combination of monoclonal antibodies (MA), based on a precise knowledge of leukemic cells immunophenotypic features. Multiple immunophenotypic aberration
Externí odkaz:
https://doaj.org/article/c0980e62a81649d6b17656c02226ff69
Autor:
A. G. Kadushkin, A. D. Tahanovich, L. V. Movchan, T. S. Kolesnikova, E. V. Khadasouskaya, T. V. Shman
Publikováno v:
Doklady Biochemistry and Biophysics. 507:307-311
Publikováno v:
Medical Immunology (Russia). 25:309-318
Currently, no drugs have been identified that could slow progression of chronic obstructive pulmonary disease (COPD), or have a significant impact on patient mortality. Therefore, research continues aimed at studying the mechanisms of COPD developmen
Autor:
A G, Kadushkin, A D, Tahanovich, L V, Movchan, M M, Zafranskaya, V V, Dziadzichkina, T V, Shman
Publikováno v:
Biomeditsinskaya Khimiya. 68:134-143
To date, there are no drugs that can prevent progressive destruction of lung tissue and small airway fibrosis in patients with chronic obstructive pulmonary disease (COPD). Therefore, molecular mechanisms of this disease are being studied. The aim of
Autor:
A. G. Kadushkin, A. D. Tahanovich, L. V. Movchan, T. S. Kolesnikova, E. V. Khadasouskaya, T. V. Shman
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 15:337-344